Ultrasep ES Pharm-PFP is a silica-based HPLC column with a pentafluorophenyl (PFP) bonded phase, specifically engineered for pharmaceutical and biotechnological applications. The PFP functionality provides a unique combination of π–π, dipole-dipole, and hydrogen-bonding interactions, offering complementary selectivity compared to conventional alkyl and phenyl phases.
This chemistry allows the separation of structurally related pharmaceuticals, stereoisomers, and polar aromatic compounds with high resolution and reproducibility. Ultrasep ES Pharm-PFP ensures robust performance and long lifetime, making it the reliable choice for method development and regulatory analysis.
Ultrasep ES Pharm-PFP delivers advanced PFP selectivity with robustness and reproducibility – the dependable choice for pharmaceutical HPLC separations.
Silica-based stationary phase with pentafluorophenyl bonded chemistry
Combines π–π, dipole-dipole, and hydrogen-bonding interactions
Superior selectivity for stereoisomers and aromatic pharmaceuticals
High reproducibility and robust column lifetime
Available particle size: 5 µm
Pharmaceutical impurity profiling and stability testing
Separation of stereoisomers and polar aromatic compounds
Biotechnological research and quality control
Method development requiring complementary selectivity to C18 or phenyl phases
| Particle Size |
|
|---|---|
| Pore Size | 100 Å |
| Particle Type | |
| USP Code | |
| pH Range | 2 - 8 |
| Phase | Material Number |
|---|---|
| Ultrasep ES Pharm-PFP, 5 µm | u15.ppfp. |